377 related articles for article (PubMed ID: 31233623)
21. Validity and Reliability of Two Digital Wound Measurement Tools after Surgery in Patients with Hidradenitis Suppurativa.
Aarts P; van Huijstee JC; Ragamin A; Reeves JL; van Montfrans C; van der Zee HH; Prens EP
Dermatology; 2023; 239(1):99-108. PubMed ID: 35998557
[TBL] [Abstract][Full Text] [Related]
22. The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.
Montero-Vilchez T; Diaz-Calvillo P; Rodriguez-Pozo JA; Cuenca-Barrales C; Martinez-Lopez A; Arias-Santiago S; Molina-Leyva A
Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206415
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.
Zouboulis CC; Tzellos T; Kyrgidis A; Jemec GBE; Bechara FG; Giamarellos-Bourboulis EJ; Ingram JR; Kanni T; Karagiannidis I; Martorell A; Matusiak Ł; Pinter A; Prens EP; Presser D; Schneider-Burrus S; von Stebut E; Szepietowski JC; van der Zee HH; Wilden SM; Sabat R;
Br J Dermatol; 2017 Nov; 177(5):1401-1409. PubMed ID: 28636793
[TBL] [Abstract][Full Text] [Related]
24. Reliability and Photographic Equivalency of the Scar Cosmesis Assessment and Rating (SCAR) Scale, an Outcome Measure for Postoperative Scars.
Kantor J
JAMA Dermatol; 2017 Jan; 153(1):55-60. PubMed ID: 27806156
[TBL] [Abstract][Full Text] [Related]
25. Convergent Validity of Suffering and Quality of Life as Measured by The Hidradenitis Suppurativa Quality of Life.
Kursawe Larsen C; Kjaersgaard Andersen R; Kirby JS; Tan J; Saunte DML; Jemec GBE
J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):1577-1581. PubMed ID: 33539563
[TBL] [Abstract][Full Text] [Related]
26. Inter-rater and intrarater agreement and reliability in clinical staging of hidradenitis suppurativa/acne inversa.
Zouboulis CC; Matusiak Ł; Jemec GBE; Szepietowski JC; Álvarez-Chinchilla PJ; Asoskova A; Bonnekoh H; Brattoli G; Cetinarslan TS; Dawicka J; Dente V; Gallyamova Y; Giovanardi G; Glasenhardt K; Ionescu AM; Janushaj E; Lakhssassi MK; Lőrincz KK; Ludew D; Makmatov-Rys M; Malickova M; Mengesha SW; Mintoff D; Otlewska A; Papakou M; Pirvan AM; Provvidenziale L; Quadrana F; Savickaja N; Tamulyté G; Trifu A; Vīgante A; Włodarek K; Zouboulis VA
Br J Dermatol; 2019 Oct; 181(4):852-854. PubMed ID: 30968946
[No Abstract] [Full Text] [Related]
27. New treatments and new assessment instruments for Hidradenitis suppurativa.
van Straalen KR; Ingram JR; Augustin M; Zouboulis CC
Exp Dermatol; 2022 Sep; 31 Suppl 1(Suppl 1):33-39. PubMed ID: 35582833
[TBL] [Abstract][Full Text] [Related]
28. Validation of a Hidradenitis Suppurativa Self-Assessment Tool.
Senthilnathan A; Kolli SS; Cardwell LA; Richardson I; Feldman SR; Pichardo RO
J Cutan Med Surg; 2019; 23(4):388-390. PubMed ID: 30897946
[TBL] [Abstract][Full Text] [Related]
29. Development and Preliminary Validation of the HSQoL-24 Tool to Assess Quality of Life in Patients With Hidradenitis Suppurativa.
Marrón SE; Gómez-Barrera M; Tomás-Aragonés L; Díaz Díaz RM; Vilarrasa Rull E; Madrid Álvarez MB; Puig L
Actas Dermosifiliogr (Engl Ed); 2019 Sep; 110(7):554-560. PubMed ID: 31023484
[TBL] [Abstract][Full Text] [Related]
30. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
[TBL] [Abstract][Full Text] [Related]
31. Clinical Characteristics of Hidradenitis Suppurativa Patients from a Reference Centre in Kaunas, Lithuania.
Kucinskiene V; Jariene V; Valiukeviciene S
Dermatology; 2020; 236(1):66-70. PubMed ID: 31940646
[TBL] [Abstract][Full Text] [Related]
32. Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.
Gergely LH; Gáspár K; Brodszky V; Kinyó Á; Szegedi A; Remenyik É; Kiss NF; Bató A; Péntek M; Gulácsi L; Sárdy M; Bánvölgyi A; Wikonkál N; Rencz F
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2584-2592. PubMed ID: 32618022
[TBL] [Abstract][Full Text] [Related]
33. Measuring disease activity and damage in discoid lupus erythematosus.
Wahie S; McColl E; Reynolds NJ; Meggitt SJ
Br J Dermatol; 2010 May; 162(5):1030-7. PubMed ID: 20199547
[TBL] [Abstract][Full Text] [Related]
34. Hidradenitis Suppurativa Quality of Life (HiSQOL): creation and validation of the Polish language version.
Krajewski PK; Matusiak Ł; Szepietowska M; Rymaszewska JE; Jemec GBE; Kirby JS; Szepietowski JC
Postepy Dermatol Alergol; 2021 Dec; 38(6):967-972. PubMed ID: 35126002
[TBL] [Abstract][Full Text] [Related]
35. Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa.
Kimball AB; Sundaram M; Banderas B; Foley C; Shields AL
J Dermatolog Treat; 2018 Mar; 29(2):152-164. PubMed ID: 28608738
[TBL] [Abstract][Full Text] [Related]
36. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
Chernyshov PV; Zouboulis CC; Tomas-Aragones L; Jemec GB; Svensson A; Manolache L; Tzellos T; Sampogna F; Pustisek N; van der Zee HH; Marron SE; Spillekom-van Koulil S; Bewley A; Linder D; Abeni D; Szepietowski JC; Augustin M; Finlay AY
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1633-1643. PubMed ID: 31037773
[TBL] [Abstract][Full Text] [Related]
37. Validation of the Three-Item Skindex-Mini Among Hidradenitis Suppurativa Patients With Diverse Racial Backgrounds.
Orenstein LAV; Amah A; Shaw FM; Zhang C; Swerlick RA; Chen SC
J Cutan Med Surg; 2020; 24(5):457-460. PubMed ID: 32469259
[TBL] [Abstract][Full Text] [Related]
38. Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the process.
Ingram JR; Hadjieconomou S; Piguet V
Br J Dermatol; 2016 Aug; 175(2):263-72. PubMed ID: 26873867
[TBL] [Abstract][Full Text] [Related]
39. Measuring Quality of Life in Hidradenitis Suppurativa: Development and Validation of a Disease-specific Patient-reported Outcome Measure for Practice and Research.
Otten M; Augustin M; Blome C; Topp J; Niklaus M; Hilbring C; Bechara FG; Pinter A; Zouboulis CC; Anzengruber F; Kirsten N
Acta Derm Venereol; 2023 Jan; 103():adv00859. PubMed ID: 36129249
[TBL] [Abstract][Full Text] [Related]
40. Interobserver variability of clinical scores in hidradenitis suppurativa is low.
Sartorius K; Killasli H; Heilborn J; Jemec GB; Lapins J; Emtestam L
Br J Dermatol; 2010 Jun; 162(6):1261-8. PubMed ID: 20184581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
